NCT00999232View on ClinicalTrials.gov

Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2007

Conditions

Pancreatitis

Interventions

DRUG

Erythromycin

Subjects receive 4x250mg erythromycin i.v. daily after intubation of a self-propelled feeding tube

DRUG

Placebo

Subjects receive 4x placebo i.v. daily after intubation of a self-propelled feeding tube

All Listed Sponsors

lead

Canisius-Wilhelmina Hospital

OTHER

NCT00999232 - Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube | Biotech Hunter | Biotech Hunter